Intraocular infusate with hemocoagulase for the control of bleeding during vitreous surgery.
The effects of hemocoagulase in injectable form (hemocoagulating enzymatic fraction of South American snake Bothrops jararaca venom provided by Ravizza) on the control of intraocular bleeding during vitreous surgery were evaluated in rabbit eyes. Intraocular infusion solution with hemocoagulase (1 NIH thrombin unit/100 ml of BSS plus) significantly reduced the bleeding time. Electroretinogram b-wave and electroretinogram c-wave showed no abnormality. Infusate with hemocoagulase (1 NIH thrombin unit/100 ml of BSS plus) is not toxic to retinal tissue and appeared to be a useful agent for the control of intraocular bleeding during vitreous surgery.
Lee
H S
HS
Kim
S H
SH
Kim
I T
IT
D000818:Animals; D012103:Batroxobin / Q000008:administration & dosage*; D005130:Eye Hemorrhage / Q000517:prevention & control*; D007267:Injections; D011817:Rabbits; D012697:Serine Endopeptidases / Q000008:administration & dosage*; D014821:Vitrectomy / Q000009:adverse effects
D012103:Batroxobin; D012697:Serine Endopeptidases